Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_012569183.1 RC1_RS19480 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_000016185.1:WP_012569183.1 Length = 390 Score = 395 bits (1015), Expect = e-114 Identities = 209/383 (54%), Positives = 261/383 (68%), Gaps = 5/383 (1%) Query: 14 RVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLDGDALRRVVEL 73 R++LLGSGELG+E AI +RLG V+A D YA APAM VA + V MLD D LR +E Sbjct: 6 RILLLGSGELGREFAISAKRLGCHVVACDSYAGAPAMQVADAAEVFPMLDADRLRDAIER 65 Query: 74 EKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRLAAEELQLPTSTYR 133 +P +IVPE+EAI T++L ++E G VVP ARAT +TMNR+ IR +AA EL L TS YR Sbjct: 66 HRPDFIVPEVEAIRTEVLQEVEARGFTVVPSARATYMTMNRDRIREVAAVELGLRTSRYR 125 Query: 134 FADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQQGGRAGAGRVI 193 +A+S A A G+PC++KPVMSSSGKGQ+ + + ++LA AW+YA R +VI Sbjct: 126 YAESLEDVEAAAAHTGFPCVIKPVMSSSGKGQSTVDAPDKLAAAWEYAVANMRGDRRKVI 185 Query: 194 VEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMSPLALERAQEIARK 253 VE ++F++EITLLTV GV FC P+GHRQE GDY+ESWQP M+P L AQE+ARK Sbjct: 186 VEEFIRFEYEITLLTVRTRQGVLFCEPIGHRQERGDYQESWQPVGMAPALLAAAQEMARK 245 Query: 254 VVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEFALHVRAFLGLPVG 313 VV LGGYG+FGVE FV DEVIFSE+SPRPHDTGMVTL+SQ LSEF LH RA LGLP+ Sbjct: 246 VVDDLGGYGIFGVEFFVTKDEVIFSELSPRPHDTGMVTLLSQTLSEFDLHARAILGLPIP 305 Query: 314 GIRQYGPAASAVILPQLTSQNVTFDNVQNAVGAD-----LQIRLFGKPEIDGSRRLGVAL 368 I GP ASAVIL S F+ + A+ + +RLFGKP RR+GVAL Sbjct: 306 AIDLRGPTASAVILADRDSDRFAFEGLAEALAVGRADQAVDVRLFGKPTTRPYRRMGVAL 365 Query: 369 ATAESVVDAIERAKHAAGQVKVQ 391 AT + +A A AA +V ++ Sbjct: 366 ATGTTAEEARRTATEAAARVHIR 388 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 397 Number of extensions: 11 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 390 Length adjustment: 31 Effective length of query: 361 Effective length of database: 359 Effective search space: 129599 Effective search space used: 129599 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory